Ticker ABT – Abbott Labs – sales, description, marketcap – Tickerday.com


Abbott Labs

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Among its well-known products across the medical devices, diagnostics, and nutrition product divisions are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.

Index: NYSE; Sector: Healthcare; Industry: Medical Equipment & Supplies;

Marketcap: 186.24B; Volume: 2.46M; AvgVol 3m: 5.24M; Beta: 0.91;

Cost estimate:

P/E: 60.85; EPS: 1.73; EPS growth quarter/prev quarter: -46.70%;

EPS growth this year: 45.20%; EPS growth past 5 years: 12.40%;

EPS ttm: 1.73;

P/S: 6.10; P/B: 6.16; P/Cashflow: 38.10; P/FCF: 89.38;

Sales: 31.44B; Sales growth quarter/prev quarter: -8.20%; Sales growth past 5 years: 9.50%;


Gross Margin: 57.70%; Profit Margin: 9.90%; Operating Margin: 12.80%;

ROA – return on assets: 4.60%; ROE – return on equity: 10.10%; LT Debt/Equity: 0.59; Total Debt/Equity: 0.64;

Dividend: 1.44; Dividend Yield (%): 1.32%;

Insider Ownership: 0.70%; Insider Transactions:-2.82%;

Institutional Ownership: 75.40%; Institutional Transactions: -0.91%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *